Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
This non-interventional study is to monitor use in real practice in Korea including adverse
 events on Aromasin (Exemestane).
All cases at the participating institutions.
Inclusion Criteria:

 -  - Postmenopausal women with breast cancer eligible for hormonal therapy.

 Exclusion Criteria:

 -  Pregnant breast-feeding premenopausal.